Business Description
![Medigene AG Medigene AG logo](https://static.gurufocus.com/logos/0C00000UDN.png?14)
Medigene AG
ISIN : DE000A1X3W00
Share Class Description:
XSWX:MDG1: Namen-Akt. nach KapitalherabsetzungCompare
Compare
Traded in other countries / regions
MDG1.GermanyMDG1.Austria0QGJ.UKMDG1.SwitzerlandMDGEF.USA IPO Date
2017-09-18Description
Medigene AG is an immuno-oncology biotechnology company. focused on developing differentiated T Cell Receptor engineered T cell (TCR-T) therapies for the treatment of multiple solid tumor indications with a high unmet medical need. The operating segments of the organization are Immunotherapies and Other products. Immunotherapies consist of T-cell receptor-based adoptive T-cell therapy and DC vaccines. The group operates in the United States, Germany, and Asia, of which the majority of the revenue is derived from operations in Germany.
Financial Strength
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 5.65 | |||||
Equity-to-Asset | 0.66 | |||||
Debt-to-Equity | 0.14 | |||||
Debt-to-EBITDA | -0.2 | |||||
Piotroski F-Score | 3/9 | |||||
Altman Z-Score | -20.52 | |||||
Beneish M-Score | -3.78 | |||||
WACC vs ROIC |
Growth Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -9 | |||||
3-Year EBITDA Growth Rate | 12.1 | |||||
3-Year EPS without NRI Growth Rate | 17.6 | |||||
3-Year FCF Growth Rate | 14.5 | |||||
3-Year Book Growth Rate | -26.6 | |||||
Future 3-5Y EPS without NRI Growth Rate | 20 |
Momentum Rank
5/10
Name | Current | Vs Industry | Vs History |
---|
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 2.53 | |||||
Quick Ratio | 2.53 | |||||
Cash Ratio | 2.32 | |||||
Days Sales Outstanding | 100.64 | |||||
Days Payable | 138.03 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Shareholder Yield % | 1.22 |
Profitability Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 72.77 | |||||
Operating Margin % | -267.63 | |||||
Net Margin % | -268.1 | |||||
FCF Margin % | -261.83 | |||||
ROE % | -54.97 | |||||
ROA % | -38.65 | |||||
ROIC % | -73.14 | |||||
ROC (Joel Greenblatt) % | -264.21 | |||||
ROCE % | -45.8 |
GF Value Rank
6/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 5.19 | |||||
PB Ratio | 1.49 | |||||
Price-to-Tangible-Book | 2.79 | |||||
EV-to-EBIT | -1.37 | |||||
EV-to-EBITDA | -1.5 | |||||
EV-to-Revenue | 3.64 | |||||
EV-to-FCF | -1.39 | |||||
Price-to-Median-PS-Value | 0.46 | |||||
Price-to-Net-Current-Asset-Value | 4.17 | |||||
Price-to-Net-Cash | 5.26 | |||||
Earnings Yield (Greenblatt) % | -72.99 | |||||
FCF Yield % | -44.25 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Medigene AG Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil CHF) | 5.79 | ||
EPS (TTM) (CHF) | 0 | ||
Beta | 0 | ||
Volatility % | 0 | ||
14-Day RSI | 0 | ||
14-Day ATR (CHF) | 0 | ||
20-Day SMA (CHF) | 0 | ||
12-1 Month Momentum % | 0 | ||
52-Week Range (CHF) | 8 - 8 | ||
Shares Outstanding (Mil) | 24.56 |
Piotroski F-Score Details
Year:
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 3 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Medigene AG Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Medigene AG Stock Events
Event | Date | Price(CHF) | ||
---|---|---|---|---|
No Event Data |
Medigene AG Frequently Asked Questions
What is Medigene AG(XSWX:MDG1)'s stock price today?
The current price of XSWX:MDG1 is CHF8.00. The 52 week high of XSWX:MDG1 is CHF8.00 and 52 week low is CHF8.00.
When is next earnings date of Medigene AG(XSWX:MDG1)?
The next earnings date of Medigene AG(XSWX:MDG1) is 2024-08-16 Est..
Does Medigene AG(XSWX:MDG1) pay dividends? If so, how much?
Medigene AG(XSWX:MDG1) does not pay dividend.
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |